Back to Search
NANCY SKLARIN, MD, MS
MD, MS
Medical Oncology Physician
NPI: 1770554487IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
151342(NY)
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 1981
Research & Publications (7)
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer.
PMID 18323546·J Clin Oncol·2008
3-trial
Arterial desaturation syndrome following pleurodesis with talc slurry: incidence, clinical features, and outcome.
PMID 14735688·Cancer Invest·2003
8-other
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
PMID 11751485·Clin Cancer Res·2001
3-trial
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial.
PMID 11510695·Breast Cancer Res Treat·2001
3-trial
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.
PMID 11352950·J Clin Oncol·2001
3-trial
Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT.
PMID 10954469·AJR Am J Roentgenol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 E 66TH ST
NEW YORK, NY 10065 - Phone
- (646) 888-5488
Quick Facts
- NPI
- 1770554487
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Publications
- 7
Are you this provider?
Claim Your Profile